Advertisement
Screener

Ascendis Pharma A/S (ASND) Current Prepayments

2.8 / 5 stars · 68/120 Roast Me

Ascendis Pharma A/S Current Prepayments

Ascendis Pharma A/S (ASND) had Current Prepayments of EUR 33.72 million as of 2025-12-31, per its 20-F filed 2026-02-11.

Financial Statements › Notes

ifrs-full:CurrentPrepayments · last filed 2026-02-11

  • 2025-12-31: Current Prepayments 33.72M EUR.
  • 2025-09-30: Current Prepayments 29.42M EUR.
  • 2025-06-30: Current Prepayments 34.31M EUR.
  • 2025-03-31: Current Prepayments 33.67M EUR.
Period endCurrent Prepayments
2025-12-3133.72M EUR
20-F · filed 2026-02-11
2025-09-3029.42M EUR
6-K · filed 2025-11-12
2025-06-3034.31M EUR
6-K · filed 2025-08-07
2025-03-3133.67M EUR
6-K · filed 2025-05-01
2024-12-3128.27M EUR
20-F · filed 2026-02-11
2024-09-3032.44M EUR
6-K · filed 2024-11-14
2024-06-3036.74M EUR
6-K · filed 2024-09-03
2024-03-3142.50M EUR
6-K · filed 2024-05-02
2023-12-3138.58M EUR
20-F · filed 2025-02-12
2023-09-3038.33M EUR
6-K · filed 2023-11-07
2023-06-3042.96M EUR
6-K · filed 2023-09-05
2023-03-3138.69M EUR
6-K · filed 2023-04-27
2023-01-0131.72M EUR
20-F · filed 2025-02-12
2022-12-3131.72M EUR
20-F · filed 2024-02-07
2022-09-3034.57M EUR
6-K · filed 2022-11-02
2022-06-3035.07M EUR
6-K · filed 2022-08-10
2022-03-3127.99M EUR
6-K · filed 2022-05-11
2021-12-3125.23M EUR
20-F · filed 2023-02-16
2021-09-3022.24M EUR
6-K · filed 2021-11-10
2021-06-3021.83M EUR
6-K · filed 2021-08-27
2021-03-3115.32M EUR
6-K · filed 2021-05-27
2020-12-3113.99M EUR
20-F · filed 2022-03-02
2020-09-3015.27M EUR
6-K · filed 2020-11-12
2020-06-3013.03M EUR
6-K · filed 2020-08-27
2020-03-3110.19M EUR
6-K · filed 2020-05-19
2019-12-317.65M EUR
20-F · filed 2021-03-10
2019-09-307.94M EUR
6-K · filed 2019-11-18
2019-06-309.89M EUR
6-K · filed 2019-08-28
2019-03-3111.28M EUR
6-K · filed 2019-05-30
2018-12-3112.41M EUR
20-F · filed 2020-04-03
2018-09-3012.39M EUR
6-K · filed 2018-11-28
2018-06-305.93M EUR
6-K · filed 2018-08-29
2018-03-317.12M EUR
6-K · filed 2018-05-30
2017-12-316.91M EUR
20-F · filed 2019-04-03
2016-12-311.96M EUR
20-F · filed 2018-03-28